Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2007
08/02/2007WO2007085681A1 Treatment substance containing magnesium salts for treatment of tumors or like and use of magnesium salts
08/02/2007WO2007085648A1 Tumour vaccine comprising allogeneic or xenogeneic tumour cells
08/02/2007WO2007085629A2 Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents
08/02/2007WO2007085412A1 Fgf2-binding peptides and uses thereof
08/02/2007WO2007085370A1 9-(dimethylamino)-methyl-10-hydroxy-camptothecin lipidester derivatives
08/02/2007WO2007085205A1 Pyrrole substituted 2-indolinone derivatives, the preparation methods and medical uses thereof
08/02/2007WO2007085204A1 γ-BUTYROLACTONE COMPOUNDS, THE PREPARATION METHODS AND MEDICAL USES THEREOF
08/02/2007WO2007076127A3 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators
08/02/2007WO2007068776B1 Antitumour compounds
08/02/2007WO2007059300A3 Anti-alk antagonist and agonist antibodies and uses thereof
08/02/2007WO2007059230A3 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
08/02/2007WO2007056151A3 Protein kinase inhbitors
08/02/2007WO2007054717A3 STAUROSPORINE DERIVATIVES FOR THE TREATMENT OF LEUKEMIA CHARACTERISED BY A SPTBNl -FLT3 MUTATION
08/02/2007WO2007045927A3 Therapeutic agent
08/02/2007WO2007040653A3 Anti-cd30 antibodies that bind to intact cd30 but not soluble cd30
08/02/2007WO2007016979A3 NOVEL HETEROCYCLIC NF-κB INHIBITORS
08/02/2007WO2007002973A3 Use of stilbene derivatives for the production of medicaments for the treatment of solid tumours
08/02/2007WO2006135713A3 Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators and a farnesyl transferase inhibitor
08/02/2007WO2006131923A3 Novel salts of conjugated psychotropic drugs and processes of preparing same
08/02/2007WO2006084027A3 Sipa-1 gene and sipa-1 inhibitor for the treatment, prevention, and diagnosis of cancer
08/02/2007WO2006052767A3 Compositions and methods for stabilizing liposomal camptothecin formulations
08/02/2007US20070180543 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
08/02/2007US20070179187 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
08/02/2007US20070179171 Vinca derivatives
08/02/2007US20070179161 Pyrazolopyrimidine compounds and their use in medicine
08/02/2007US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use
08/02/2007US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
08/02/2007US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example
08/02/2007US20070179112 Polymeric nucleoside prodrugs
08/02/2007US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents
08/02/2007US20070179099 Methods of cholesterol reduction using isoflavones
08/02/2007US20070179097 GnRH agonist combination drugs
08/02/2007US20070178540 Goodpasture antigen binding protein
08/02/2007US20070178509 kit for the diagnosis or detection of cancer in a mammal; biomarkers for distinguishing between tumors of differing metastatic potential
08/02/2007US20070178177 Beverage and medicament containing bamboo extract as a main ingredient
08/02/2007US20070178118 Physiologically active composition and preparing method thereof
08/02/2007US20070178114 Novel kallikrein gene
08/02/2007US20070178105 FHIT proteins and nucleic acids and methods based thereon
08/02/2007US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual
08/02/2007US20070178093 Lymphocytes; methods
08/02/2007US20070178092 Humanized anti-CD3 specific antibodies
08/02/2007US20070178091 Combination Therapy
08/02/2007US20070178082 Stabilized single domain antibodies
08/02/2007US20070178064 Use to enhance apoptosis; antiproliferative agents; IAP (inhibitor-of apoptosis)
08/02/2007DE102006002649A1 New aza-heterocycle compounds are tyrosine kinase inhibitors useful to treat and/or prevent e.g. cancer, tumor growth, tumor angiogenesis, arteriosclerosis, diabetic retinopathy and inflammation diseases
08/02/2007DE10138935B4 Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen, unter deren Verwendung hergestellte monoclonale Antikörper, diese umfassende Antitumormittel Immunstimulantien und Mittel gegen das humane Immundefizienzvirus Synthetic compounds from non-mucin or its conjugated with a carrier compounds monoclonal antibody prepared using them, this comprehensive antitumor agents and immunostimulants agents against human immunodeficiency virus
08/02/2007CA2640375A1 Pyrimidine derivatives
08/02/2007CA2640159A1 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents
08/02/2007CA2637933A1 Indole sulfonamide modulators of progesterone receptors
08/02/2007CA2637690A1 Tumour vaccine comprising allogeneic or xenogeneic tumour cells
08/02/2007CA2637335A1 Thiophene-carboxamides useful as inhibitors of protein kinases
08/02/2007CA2637295A1 Fgf2-binding peptides and uses thereof
08/02/2007CA2627607A1 Fap inhibitors
08/01/2007EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby
08/01/2007EP1813625A1 Method of modulating the profileration of medullary thyroid carcinoma cells
08/01/2007EP1813613A1 Novel fused imidazole derivative
08/01/2007EP1813607A2 Tetraaza- or N2S2- complexants, and their use in radiodiagnostics or radiotherapy
08/01/2007EP1813602A1 Crystal of two-ring heterocyclic sulfonamide compound
08/01/2007EP1813289A1 Medicinal composition for treating cancer or diabetes
08/01/2007EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base
08/01/2007EP1813270A1 Hsp90 family protein inhibitors
08/01/2007EP1812797A2 Compositions and methods for the treatment and prevention of hyperproliferative diseases
08/01/2007EP1812570A1 Improved treatment of cancer using tlr3 agonists
08/01/2007EP1812468A2 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis
08/01/2007EP1812466A2 Compositions and methods for the control of mammary cell number
08/01/2007EP1812451A2 Compounds and methods of use thereof
08/01/2007EP1812450A2 Tgf-beta inhibitors
08/01/2007EP1812442A2 Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity
08/01/2007EP1812441A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors
08/01/2007EP1812440A1 PYRAZOLOÝ1,5-a¨PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
08/01/2007EP1812439A2 Kinase inhibitors
08/01/2007EP1812433A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
08/01/2007EP1812425A2 C-fms kinase inhibitors
08/01/2007EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
08/01/2007EP1812071A2 Compounds for nonsense suppression, use of these compounds for the manufacture of a medicament for treating somatic mutation-related diseases
08/01/2007EP1812036A2 Histone deacetylase inhibitors and methods of use
08/01/2007EP1812035A2 Peptide anti - tumor agent
08/01/2007EP1812018A1 Treatment and prevention of multi-drug resistance
08/01/2007EP1812011A1 Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
08/01/2007EP1811998A1 Triazoles useful as inhibitors of protein kinases
08/01/2007EP1811997A2 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors
08/01/2007EP1811994A1 Novel derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy
08/01/2007EP1811963A2 Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
08/01/2007EP1811842A2 3,3'-diindolylmethane immune activating compositions
08/01/2007EP1811840A2 Anti-tumor compounds with angeloyl groups
08/01/2007EP1581528B1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
08/01/2007EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors
08/01/2007EP1507760B1 Cyanoguanidine prodrugs
08/01/2007EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof
08/01/2007EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
08/01/2007EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/01/2007EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity
08/01/2007EP1351712B1 Targeted combination immunotherapy of cancer and infectious diseases
08/01/2007EP1294714B1 Thrombin receptor antagonists
08/01/2007EP1294401B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
08/01/2007EP1259235B1 Tyrosine kinase inhibitors
08/01/2007EP1187592B1 Alpha v integrin receptor antagonists
08/01/2007EP1019060B1 Androgen synthesis inhibitors
08/01/2007CN1329512C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
08/01/2007CN1329398C Dihydroporphine E6 zinc compound photosensitizer and its preparation method and application
1 ... 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 ... 2211